Target intelligence / Profile preview

Arsenate reductase (ArsC)

Target
ArsC
Molecular classification
Enzyme, Oxidoreductase
01

Overview

Arsenate reductase (ArsC) is an enzyme encoded by the arsC gene, found in bacteria such as *Escherichia coli* and *Staphylococcus aureus*. ArsC catalyzes the reduction of toxic arsenate (As(V)) to arsenite (As(III)), which can then be extruded from the cell. This reaction is a crucial component of prokaryotic resistance to arsenic compounds, allowing microorganism survival in arsenic-contaminated environments. The enzyme displays a unique protein fold and typically requires redox partners such as glutaredoxin or thioredoxin, depending on the bacterial species. ArsC is not directly targeted by any approved drugs, but inhibition could sensitize bacteria to arsenic toxicity, making it a possible target for environmental biotechnology or infectious disease control in specific organisms[1][2][3][4][5][6][7][8]. It is not linked to human disease outside of its environmental context.

Other names
arsenate reductaseArsC protein
02

Mechanism of action

Catalyzes the reduction of **arsenate (As(V))** to **arsenite (As(III))** through a glutaredoxin-dependent or thioredoxin-dependent pathway, enabling bacterial resistance to arsenate toxicity[1][2][3][4][8].

03

Biological functions

Arsenate reductionDetoxification of arsenic compoundsCellular resistance to toxic anions
04

Disease associations

InfectionOther (environmental arsenic detoxification; not directly implicated in classical human diseases but important in bacterial survival against arsenic toxicity)
05

Safety considerations

null (No specific therapeutic safety concerns, as it is not a human therapeutic target; main challenge is environmental persistence and bioremediation efficacy.)
06

Interacting drugs

null (There are no approved drugs targeting bacterial ArsC, but it is under investigation as a potential antimicrobial or bioremediation target[7].)
07

Biomarkers

null (ArsC itself is not a clinically validated biomarker, but its expression is used as an indicator for arsenic resistance in microbiological and environmental studies.)

Beyond the preview

Go deeper on Arsenate reductase (ArsC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arsenate reductase (ArsC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call